Drugs Made In America Acq...

NASDAQ: DMAA · Real-Time Price · USD
10.26
-0.02 (-0.19%)
At close: Aug 19, 2025, 3:58 PM

Drugs Made In America Acquisition Ordinary Shares Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024
Period Ending Dec 31, 2024
Revenue
n/a
Cost of Revenue
n/a
Gross Profit
n/a
Operating Income
-479
Interest Income
n/a
Pretax Income
-479
Net Income
-479
Selling & General & Admin
479.73
Research & Development
n/a
Other Expenses
n/a
Operating Expenses
479.73
Interest Expense
n/a
Selling & Marketing Expenses
n/a
Cost & Expenses
479.73
Income Tax Expense
n/a
Shares Outstanding (Basic)
8.57K
Shares Outstanding (Diluted)
8.57K
EPS (Basic)
-0.06
EPS (Diluted)
-0.06
EBITDA
n/a
EBIT
-479
Depreciation & Amortization
479.73